phenytoin has been researched along with trifluoperazine in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (60.71) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 3 (10.71) | 29.6817 |
| 2010's | 6 (21.43) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Duffy, EM; Jorgensen, WL | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Monroe, RR | 1 |
| Besser, GM; Grossman, A; Rees, LH; Tsagarakis, S | 1 |
| Cooper, CW; Seitz, PK; Yi, SJ | 1 |
| Cooper, CW; Seitz, PK | 1 |
| Drouva, SV; Kordon, C; Laplante, E | 1 |
| Arnold, K; Gerber, N | 1 |
| Grinberg, KN; Shapiro, IuL; Vaĭntrub, MIa; Zhurkov, VS | 1 |
| Bick, M; Fishbein, L | 1 |
| Trautmann, A | 1 |
| Frisch, EP; Jones, D; Madden, JS | 1 |
| Zlotlow, M | 1 |
| Goulding, R; Kramer, MD; Monroe, RR; Wise, S | 1 |
| Snyder, S | 1 |
| Drouva, SV; Epelbaum, J; Kordon, C; Laplante, E | 1 |
| Erlichman, J; Fleckman, A; Fleischer, N; Schubart, UK | 1 |
| Chernokhvostov, VV; Freydin, AA; Kosarsky, LS; Lazarev, AV; Saxon, ME | 1 |
| BARSA, JA; SAUNDERS, JC | 1 |
3 review(s) available for phenytoin and trifluoperazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Teratogenic and mutagenic effects of anticonvulsive and psychotropic drugs (review of the literature)].
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Animals; Anticonvulsants; Antidepressive Agents; Arm; Barbiturates; Chlorpromazine; Chromosome Aberrations; Chromosome Disorders; Cricetinae; Drosophila; Female; Heart Defects, Congenital; Humans; Imipramine; Infant, Newborn; Jaundice, Neonatal; Mutagens; Perphenazine; Phenothiazines; Phenytoin; Pregnancy; Primidone; Rabbits; Thalidomide; Tranquilizing Agents; Trifluoperazine | 1972 |
The interaction of psychopharmacology and psychoanalysis in the borderline patient.
Topics: Affect; Anger; Antipsychotic Agents; Borderline Personality Disorder; Chlorpromazine; Clinical Trials as Topic; Depression; Double-Blind Method; Ego; Female; Humans; Imipramine; Lithium; Male; Methods; Personality Disorders; Phenytoin; Procyclidine; Psychoanalytic Interpretation; Tranylcypromine; Trifluoperazine | 1980 |
2 trial(s) available for phenytoin and trifluoperazine
| Article | Year |
|---|---|
Anticonvulsants in the treatment of aggression.
Topics: Adult; Aggression; Anticonvulsants; Chlordiazepoxide; Chlorpromazine; Drug Therapy, Combination; Epilepsy; Humans; Impulsive Behavior; Male; Mental Disorders; Neurocognitive Disorders; Phenytoin; Primidone; Schizophrenia; Trifluoperazine; Violence | 1975 |
The interaction of psychopharmacology and psychoanalysis in the borderline patient.
Topics: Affect; Anger; Antipsychotic Agents; Borderline Personality Disorder; Chlorpromazine; Clinical Trials as Topic; Depression; Double-Blind Method; Ego; Female; Humans; Imipramine; Lithium; Male; Methods; Personality Disorders; Phenytoin; Procyclidine; Psychoanalytic Interpretation; Tranylcypromine; Trifluoperazine | 1980 |
24 other study(ies) available for phenytoin and trifluoperazine
| Article | Year |
|---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Involvement of calmodulin in depolarization-induced release of corticotrophin-releasing hormone-41 from the rat hypothalamus in vitro.
Topics: Animals; Calcimycin; Calcium; Calmodulin; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Hypothalamus; In Vitro Techniques; Membrane Potentials; Phenytoin; Potassium Chloride; Radioimmunoassay; Rats; Trifluoperazine; Verapamil; Veratridine | 1991 |
Inhibition by phenytoin of in vitro secretion of calcitonin from rat thyroid glands and cultured rat C cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcitonin; Calcium; Cells, Cultured; In Vitro Techniques; Nitrendipine; Phenytoin; Rats; Reference Values; Thyroid Gland; Thyroid Neoplasms; Trifluoperazine | 1988 |
Cosecretion of calcitonin and calcitonin gene-related peptide from cultured rat medullary thyroid C cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcitonin; Calcitonin Gene-Related Peptide; Neuropeptides; Nitrendipine; Phenytoin; Phorbol Esters; Rats; Thyroid Neoplasms; Trifluoperazine; Tumor Cells, Cultured; Vasodilator Agents | 1989 |
Progesterone-induced LHRH release in vitro is an estrogen--as well as Ca++- and calmodulin-dependent secretory process.
Topics: Animals; Calcium; Calmodulin; Castration; Culture Techniques; Estradiol; Female; Gonadotropin-Releasing Hormone; Hypothalamus, Middle; Ion Channels; Phenytoin; Progesterone; Rats; Rats, Inbred Strains; Tetrodotoxin; Trifluoperazine | 1985 |
The effect of diphenyl-piperazine compounds and other agents on diphenylhydantoin, zoxazolamine and hexobarbital metabolism.
Topics: Animals; Benzopyrenes; Cyclizine; DDT; Diphenhydramine; Endoplasmic Reticulum; Hexobarbital; Humans; Hydroxyzine; Liver; Male; Meclizine; Methylcholanthrene; Mice; Microscopy, Electron; Phenethylamines; Phenobarbital; Phenytoin; Piperazines; Trifluoperazine; Zoxazolamine | 1968 |
Effect of certain drugs and environmental agents on microsomal enzyme systems.
Topics: Aminopyrine N-Demethylase; Animals; Anisoles; Aspirin; Cytochrome P-450 Enzyme System; DDT; Enzyme Induction; Intestine, Small; Kidney; Lung; Male; Microsomes; Microsomes, Liver; Morphinans; Nitro Compounds; Oxidoreductases, N-Demethylating; Phenacetin; Phenanthrenes; Phenobarbital; Phenytoin; Rats; Transferases; Trifluoperazine | 1972 |
[Dialysis of drugs and poisons. 2].
Topics: Acetaminophen; Aminopyrine; Amitriptyline; Aspirin; Carbamazepine; Chlordiazepoxide; Chlorpromazine; Dextropropoxyphene; Diazepam; Heroin; Humans; Imipramine; Lithium; Pargyline; Pentazocine; Phenacetin; Phenelzine; Phenytoin; Poisoning; Primidone; Promazine; Renal Dialysis; Salicylates; Tranylcypromine; Trifluoperazine | 1972 |
Chlormethiazole and trifluoperazine in alcohol withdrawal.
Topics: Alcoholism; Chlormethiazole; Coma; Depression; Feeding and Eating Disorders; Female; Headache; Humans; Liver Function Tests; Male; Methaqualone; Nausea; Phenytoin; Sleep; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Trifluoperazine | 1969 |
Temporal lobe "spike focus" associated with confusion, complete amnesia and fugues in a paranoid schizophrenic.
Topics: Adult; Amnesia; Chlorpromazine; Cognition Disorders; Dissociative Disorders; Electroencephalography; Epilepsy, Temporal Lobe; Humans; Male; Paranoid Disorders; Phenobarbital; Phenytoin; Schizophrenia; Time Factors; Trifluoperazine | 1968 |
EFG activation of patients receiving phenothiazines and chlordiazepoxide.
Topics: Adult; Anxiety; Cerebral Cortex; Chloralose; Chlordiazepoxide; Chlorpromazine; Depression; Electroencephalography; Epilepsy; Female; Humans; Male; Middle Aged; Phenothiazines; Phenytoin; Schizophrenia; Trifluoperazine | 1965 |
Calmodulin involvement on the Ca++-dependent release of LHRH and SRIF in vitro.
Topics: Animals; Calcimycin; Calcium; Calmodulin; Gonadotropin-Releasing Hormone; Hypothalamus, Middle; In Vitro Techniques; Male; Phenytoin; Potassium; Rats; Rats, Inbred Strains; Somatostatin; Trifluoperazine; Veratridine | 1984 |
Effect of trifluoperazine, D600, and phenytoin on depolarization- and thyrotropin-releasing hormone-induced thyrotropin release from rat pituitary tissue.
Topics: Animals; Calcium; Gallopamil; Ion Channels; Male; Membrane Potentials; Phenytoin; Pituitary Gland, Anterior; Potassium; Rats; Sodium; Thyrotropin; Thyrotropin-Releasing Hormone; Trifluoperazine; Verapamil; Veratridine | 1981 |
Calmodulin-dependent regulation of calcium-activated outward current in frog atrial membrane.
Topics: Animals; Calcium; Calcium-Binding Proteins; Calmodulin; Electrocardiography; Heart Atria; Ion Channels; Myocardial Contraction; Phenytoin; Potassium; Rana ridibunda; Trifluoperazine | 1982 |
BENZQUINAMIDE IN THE TREATMENT OF PSYCHOTIC PATIENTS.
Topics: Chlorpromazine; Chlorprothixene; Drug Therapy; Humans; Mental Disorders; Phenytoin; Psychotic Disorders; Quinolizines; Thioridazine; Tranquilizing Agents; Trifluoperazine; Trimeprazine | 1964 |